• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Delta Apparel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

    10/3/23 8:02:47 AM ET
    $AGIL
    $ALXO
    $ASNS
    $AWIN
    Professional Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGIL alert in real time by email

    Gainers

    VIQ Solutions Inc. (NASDAQ:VQS) shares rose 88.5% to $0.2470 in pre-market trading after falling 18% on Monday. VIQ Solutions recently announced delisting from the Nasdaq.

    Molekule Group, Inc. (NASDAQ:MKUL) shares gained 31.4% to $0.1960 in pre-market trading.

    AgileThought, Inc. (NASDAQ:AGIL) shares rose 28.8% to $0.2060 in pre-market trading after gaining 9% on
    Monday.

    ALX Oncology Holdings Inc. (NASDAQ:ALXO) shares rose 26.8% to $6.10 in pre-market trading. ALX Oncology Holdings is scheduled to host an investor call and webcast on Oct. 3 to share interim Phase 2 ASPEN-06 clinical trial results of evorpacept for the treatment of advanced HER2-positive gastric cancer.

    SIGNA Sports United N.V. (NYSE:SSU) shares surged 22.9% to $0.1903 in pre-market trading after falling 44% on Monday. SIGNA Sports recently announced an acceleration of its strategic realignment and performance enhancement program.

    Loop Media, Inc. (NYSE:LPTV) rose 19.6% to $0.58 in pre-market trading.

    Renalytix Plc (NASDAQ:RNLX) rose 15.3% to $1.73 in pre-market trading after falling 6% on Monday. Renalytix recently reported worse-than-expected FY23 revenue results and issued FY24 guidance.

    MSP Recovery, Inc. (NASDAQ:LIFW) shares climbed 12.9% to $0.2260 in pre-market trading after falling around 7% on Monday.

    SeaStar Medical Holding Corporation (NASDAQ:ICU) gained 10.3% to $0.4601 in pre-market trading after jumping 58% on Monday. SeaStar Medical was recently granted Breakthrough Device Designation by the FDA for its Selective Cytopheretic Device for Cardiorenal Syndrome.

    Delta Apparel, Inc. (NYSE:DLA) shares jumped 8.1% to $7.12 in pre-market trading after the company said it received an unsolicited offer to purchase its Salt Life business.

    Losers

    AERWINS Technologies Inc. (NASDAQ:AWIN) fell 17.9% to $0.1880 in pre-market trading. AERWINS Technologies shares jumped around 90% on Monday after the company said it is considering strategic alternatives for its non-core operations.

    SmileDirectClub, Inc. (NASDAQ:SDC) fell 15.6% to $0.1360 in pre-market trading. SmileDirectClub received a written notice from Nasdaq that Nasdaq had determined that company's securities will be delisted from Nasdaq and suspended at opening of business on Oct. 4, 2023.

    Nisun International Enterprise Development Group Co., Ltd (NASDAQ:NISN) shares fell 15.6% to $2.00 in pre-market trading.

    Actelis Networks, Inc. (NASDAQ:ASNS) fell 13.6% to $1.08 in pre-market trading after gaining around 14% on Monday. Actelis recently announced it achieved Third Party Validation for FIPS cyber protection standard required by government agencies.

    NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) fell 10.3% to $0.2574 in pre-market trading after gaining 10% on Monday. NRx Pharmaceuticals announced FDA permission to proceed on Investigational New Drug application for NRX-101 to treat chronic pain.

    Eastside Distilling, Inc. (NASDAQ:EAST) fell 9.7% to $1.48 in pre-market trading after gaining 33% on Monday. The company recently announced the successful completion of a debt-for-equity exchange with key first and second lien debt holders.

    OpGen, Inc. (NASDAQ:OPGN) shares fell 9.6% to $0.3799 in pre-market trading after gaining 5% on Monday. OpGen recently requested to withdraw its registration statement on Form S-1.

    Better Choice Company Inc. (NYSE:BTTR) shares fell 9.6% to $0.1410 in pre-market trading after surging more than 25% on Monday.

    IceCure Medical Ltd (NASDAQ:ICCM) fell 8.9% to $0.7788 in pre-market. IceCure Medical shares jumped 54% on Monday after the company announced an independent study validated its ProSense cryoblation treatment as a safe and effective outpatient procedure for breast cancer with a 96.8% success rate.

    Femasys Inc. (NASDAQ:FEMY) fell 8% to $3.58 in pre-market trading after gaining more than 30% on Monday.

    Now Read This: McCormick, Delta Apparel And 3 Stocks To Watch Heading Into Tuesday

    Get the next $AGIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGIL
    $ALXO
    $ASNS
    $AWIN

    CompanyDatePrice TargetRatingAnalyst
    ALX Oncology Holdings Inc.
    $ALXO
    3/19/2026$5.00Overweight
    Wells Fargo
    ALX Oncology Holdings Inc.
    $ALXO
    3/6/2026$6.00Buy
    UBS
    Femasys Inc.
    $FEMY
    11/20/2025$6.50Buy
    Laidlaw
    ALX Oncology Holdings Inc.
    $ALXO
    11/13/2025$4.00Buy
    Jefferies
    NRX Pharmaceuticals Inc.
    $NRXP
    9/8/2025$40.00Buy
    H.C. Wainwright
    NRX Pharmaceuticals Inc.
    $NRXP
    4/2/2025$18.00Buy
    BTIG Research
    ALX Oncology Holdings Inc.
    $ALXO
    3/6/2025$2.00 → $3.00Hold → Buy
    Jefferies
    ALX Oncology Holdings Inc.
    $ALXO
    12/19/2024$12.00 → $2.00Buy → Hold
    Jefferies
    More analyst ratings

    $AGIL
    $ALXO
    $ASNS
    $AWIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Knight Jeff E.

    4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)

    4/17/26 4:15:03 PM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Klencke Barbara

    4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)

    4/17/26 4:15:02 PM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Knight Jeff E.

    3 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)

    4/17/26 4:10:03 PM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $ALXO
    $ASNS
    $AWIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wells Fargo initiated coverage on ALX Oncology with a new price target

    Wells Fargo initiated coverage of ALX Oncology with a rating of Overweight and set a new price target of $5.00

    3/19/26 8:25:33 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    UBS resumed coverage on ALX Oncology with a new price target

    UBS resumed coverage of ALX Oncology with a rating of Buy and set a new price target of $6.00

    3/6/26 8:38:03 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Laidlaw initiated coverage on Femasys with a new price target

    Laidlaw initiated coverage of Femasys with a rating of Buy and set a new price target of $6.50

    11/20/25 8:06:38 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    $AGIL
    $ALXO
    $ASNS
    $AWIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Actelis Networks Commences Trading on the OTCQB Venture Market

    SUNNYVALE, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (OTCQB:ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid-deployment networking solutions for IoT and broadband applications, today announced that its common stock has commenced trading on the OTCQB Venture Market operated by OTC Markets Group, effective at the open of business on April 24, 2026. The Company's common stock continues to trade under the symbol "ASNS." The transition to OTCQB follows the Company's previously announced move from The Nasdaq Capital Market to the OTC Markets, and the Company's application to the OTCQB Venture Market. OTCQB is a marketplace designed for devel

    4/24/26 10:27:19 AM ET
    $ASNS
    Telecommunications Equipment
    Telecommunications

    Actelis Networks Secures New Order for Alaska State Department of Transportation Intelligent Transportation System Project

    Sunnyvale, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (OTC:ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid-deployment networking solutions for IoT and broadband applications, today announced that it has received an order to supply its hybrid fiber-copper networking solution for an intelligent transportation system ("ITS") project for the Alaska State Department of Transportation. The order, placed through one of Actelis' long-standing partners, supports the modernization of traffic signal and cabinet infrastructure in the Anchorage area. "Our growing list of U.S. state,county and municipal transportation customers includes the State of A

    4/23/26 9:28:01 AM ET
    $ASNS
    Telecommunications Equipment
    Telecommunications

    Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

    ATLANTA, April 22, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the commercial launch of FemaSeed Complete, a comprehensive fertility solution that enables OB/GYNs to perform first-line insemination entirely within their own practices. An estimated 10 million women in the United States experience infertility, yet fewer than half access care, and only a very small percentage ultimately undergo IVF. At the same time, U.S. fertility rates declined again in 2025 to a record low, underscoring the growing need for ear

    4/22/26 9:00:00 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    $AGIL
    $ALXO
    $ASNS
    $AWIN
    SEC Filings

    View All

    SEC Form 6-K filed by IceCure Medical Ltd.

    6-K - IceCure Medical Ltd. (0001584371) (Filer)

    4/22/26 5:28:16 PM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    SEC Form 6-K filed by IceCure Medical Ltd.

    6-K - IceCure Medical Ltd. (0001584371) (Filer)

    4/21/26 8:45:12 AM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    SEC Form DEF 14A filed by ALX Oncology Holdings Inc.

    DEF 14A - ALX ONCOLOGY HOLDINGS INC (0001810182) (Filer)

    4/20/26 4:05:19 PM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $ALXO
    $ASNS
    $AWIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Goodman Corey S bought $4,999,999 worth of shares (3,184,713 units at $1.57) (SEC Form 4)

    4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)

    2/4/26 4:15:59 PM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Baird Jennifer A bought $987 worth of shares (4,200 units at $0.24), increasing direct ownership by 13% to 36,200 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    12/22/25 6:55:38 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Messinger Michael bought $5,098 worth of shares (14,500 units at $0.35), increasing direct ownership by 483% to 17,500 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    12/11/25 6:49:59 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    $AGIL
    $ALXO
    $ASNS
    $AWIN
    Financials

    Live finance-specific insights

    View All

    IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025

    The Company's participation at the Society of Breast Imaging Symposium and other upcoming medical conferences are timely as commercial momentum acceleratesCryoablation cost analysis study from Massachusetts General Hospital featuring ProSense® demonstrated 50% reduction in cost vs. lumpectomy won SBI 2026 Abstract AwardCAESAREA, Israel, April 21, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that it expects to report U.S. revenue of ProSense® systems and cryoprobes increased more than 30% in

    4/21/26 8:30:00 AM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update

    ATLANTA, March 31, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results for the year ended December 31, 2025 and provides a corporate update. Corporate Highlights from 4Q 2025 to date Initiated patient enrollment in the FINALE pivotal clinical trial evaluating FemBloc, advancing toward U.S. approval.Appointed Kenneth D. Eichenbaum, M.D., M.S.E., to the Board of Directors, strengthening leadership and strategic oversight.FemBloc permanent birth control system achieved certification under the Medical Device Single Au

    3/31/26 4:05:00 PM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

    Added top-rated children's hospitals to QUELIMMUNE™ pediatric Acute Kidney Injury (AKI) customer base Completed enrollment in FDA-mandated QUELIMMUNE SAVE Post-Marketing Registry Exceeded 50% enrollment milestone in pivotal trial of SCD therapy in adult patients with AKI Advanced pipeline indications with initiation of cardio-renal clinical trial Webcast today at 4:30 pm Eastern Time DENVER, March 25, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today financial results for the three months and yea

    3/25/26 4:05:00 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    $AGIL
    $ALXO
    $ASNS
    $AWIN
    Leadership Updates

    Live Leadership Updates

    View All

    ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

    - Veteran biopharmaceutical and oncology leader brings more than three decades of experience across clinical development, regulatory, and operational execution SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (("ALX Oncology, NASDAQ:ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, announced the appointment of Jeff Knight, M.P.H., as Chief Development and Operating Officer, effective April 13, 2026. "Jeff is a highly accomplished leader with deep expertise across clinical development and operations, and a strong track record of both advancing innovative thera

    4/13/26 8:30:00 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company's first Chief Commercial Officer

    Mr Tyson has both clinical experience treating patients with serious mental health disorders and 25 years of successful industry commercial experience in the development and sales of medications in this fieldMr. Tyson is appointed as NRx anticipates approval of an ANDA for preservative-free ketamine and near term submission of a New Drug Application to expand ketamine labeling to encompass depression and suicidality. WILMINGTON, Del., April 13, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a biopharmaceutical company that focuses on neuroplastic therapies for depression, PTSD, and related conditions, today announces the appointment of Glenn Tyson as the company's first

    4/13/26 7:00:00 AM ET
    $NRXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth

    ATLANTA, April 01, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the appointment of John Canning as Chief Operating Officer. Mr. Canning is an accomplished medical device executive with more than 25 years of experience leading global operations and technology organizations within complex medical device companies. He brings a track record of scaling organizations, advancing product pipelines, and driving operational excellence across key functions to support commercial growth and product adoption. Prior to joining

    4/1/26 9:00:00 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    $AGIL
    $ALXO
    $ASNS
    $AWIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by IceCure Medical Ltd.

    SC 13G/A - IceCure Medical Ltd. (0001584371) (Subject)

    11/14/24 9:38:43 PM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by ALX Oncology Holdings Inc.

    SC 13G/A - ALX ONCOLOGY HOLDINGS INC (0001810182) (Subject)

    11/14/24 7:22:54 PM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care